DBVTDBV Technologies
DBVT
DBV Technologies2,445
Mkt Cap
$779.45MVolume
493,151.0052W High
$20.1652W Low
$2.74PE Ratio
-3.81DBVT Fundamentals
Price
$19.43Prev Close
$20.00Open
$20.8550D MA
$14.48Beta
0.49Avg. Volume
142,175.16EPS (Annual)
-$5.86P/B
10.35Rev/Employee
$0.00DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
109
Frequently Asked Questions
What is Market Cap of DBV Technologies - ADR?
What is the 52-week high for DBV Technologies - ADR?
What is the 52-week low for DBV Technologies - ADR?
What is DBV Technologies - ADR stock price today?
What was DBV Technologies - ADR stock price yesterday?
What is the PE ratio of DBV Technologies - ADR?
What is the Price-to-Book ratio of DBV Technologies - ADR?
What is the 50-day moving average of DBV Technologies - ADR?
How many employess does DBV Technologies - ADR has?